Acetylsalicylic acid Completed Phase 4 Trials for Atherosclerosis Basic Science

IndicationsStatusPurposePhase
CompletedBasic Science4
clinicaltrials.gov IdentifierTitleDrugs
NCT02234427Pharmacogenomics of Antiplatelet Response